![U.S. aims to share up to 60 million AstraZeneca vaccine doses with other countries after FDA review](https://cbsnews2.cbsistatic.com/hub/i/r/2021/03/29/10bab624-7d98-4a74-b0b0-b0188bb097e5/thumbnail/1200x630/517040864d71a4e3d96f99f72c37b5ee/cbsn-fusion-pres-biden-announces-90-percent-of-adults-will-be-eligible-for-covid-19-vaccine-by-april-19-thumbnail-680157-640x360.jpg)
U.S. aims to share up to 60 million AstraZeneca vaccine doses with other countries after FDA review
CBSN
The Biden administration is planning to share up to 60 million doses of AstraZeneca's COVID-19 vaccine with other countries, officials confirmed Monday. The decision comes after the White House has faced growing calls to share shots that are likely to otherwise go unused in the United States.
Some 10 million doses manufactured in the U.S. could be shipped out to other countries within the "coming weeks," White House press secretary Jen Psaki said Monday. But Psaki noted that the shots first need to clear safety reviews by federal regulators. "Given the strong portfolio of vaccines that the United States has already authorized and that is available in large quantities, including two two-dose vaccines and one one-dose vaccine, and given AstraZeneca is not authorized for use in the United States, we do not need to use AstraZeneca in our fight against COVID over the next few months," Psaki told reporters.More Related News
![](/newspic/picid-6252001-20250206120759.jpg)
Since ChatGPT was released just over two years ago, its use everywhere from the workplace to academia has expanded significantly. In schools across the country, teachers and administrators have been grappling with how to contend with this new tool. While some say it has benefits, others point out the negatives, like cheating.